Skip to content

Photodynamic Therapy for Cutibacterium Acnes (C. Acnes) Decolonization of the Shoulder Dermis

Photodynamic Therapy for Cutibacterium Acnes (C. Acnes) Decolonization of the Shoulder Dermis

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04636242
Enrollment
120
Registered
2020-11-19
Start date
2019-08-22
Completion date
2021-08-31
Last updated
2020-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroscopic Rotator Cuff Repair, C. Acnes, Phototherapy, Postoperative Infection, Shoulder Surgery

Brief summary

This is a prospective, randomized controlled trial to evaluation the ability of 5-aminolevulinic acid HCL topical solution photodynamic therapy to decrease the colonization of Cutibacterium acnes (C. acnes- a bacteria commonly found in the dermis of the skin surrounding the shoulder) in order to decrease postoperative joint infections. -Aminolevulinic acid (ALA) is a naturally occurring metabolite in the synthesis of pathway of cellular heme production. Adding ALA to bacteria encourages porphyrin production which serve as the immediate precursors to heme production. When these porphyrins are illuminated with blue light at an emission peak of 407-420nm, these metabolites become exothermic and cause internal destruction of the bacterial cells. This therapy does not cause any damage to the mammalian cells, which makes PDT safe for human skin treatment.

Interventions

PROCEDURESkin Biopsy

A Biopsy of the skin where the arthroscopic instrument will be placed, will be taken and sent to the microbiology lab for analysis

DRUG5 Aminolevulinic Acid + Phototherapy

5 aminolevulinic acid solution will be placed on the skin of the shoulder and the participant will receive Photodynamic therapy on the morning of surgery

Sponsors

Rothman Institute Orthopaedics
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* All male patients (\>18) undergoing shoulder arthroscopy)

Exclusion criteria

* Female patients * Patients with active acnes * Patients who have taken antibiotics within a month of their surgery * Subjects with psoriatic/eczematous lesions on the shoulder girdle * Patients on anticoagulant therapy * Patients who have a known allergy to any of the agents used in the study protocol

Design outcomes

Primary

MeasureTime frame
Change in the number of patients who have microbiological results positive for the bacteria C. acnes after treatment with 5-aminolevulinic acid-photodynamic therapy (ALA-PDT) versus those who were not.13 days

Secondary

MeasureTime frameDescription
Decrease Rate of Postoperative Infection3 monthsThe change in the incidence of postoperative shoulder infections in participants treated with photodynamic therapy versus participants who were not

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026